Adjuvant Chemotherapy and Survival After Pelvic Exenteration for Gynecologic Cancers in the COREPEX Study

This comparative effectiveness research study investigates whether adjuvant chemotherapy is associated with survival in patients with gynecologic cancer undergoing pelvic exenteration with pelvic lymph node metastasis.

Corresponding Author: Sahar Salehi, PhD, Department of Pelvic Cancer and Women’s and Children’s Health, Karolinska University Hospital and Karolinska Institutet, Nobels väg 6, 171 77, Stockholm, Sweden (sahar.salehi@ki.se).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.